Carcinoma: all 6,719 studies
Page 11 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.RecruitingNCT04737382Not applicable
- Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell CarcinomaNot yet recruitingNCT04716751Phase 2
- Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous CarcinomaRecruitingNCT04716686Phase 2
- PITCHER (Peritoneal Carcinomatosis Heterogeneity)RecruitingNCT04714957
- Urine Omics Predicting IO Therapy Responses in mRCC PatientsRecruitingNCT04712305
- Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCCRecruitingNCT04688528Not applicable
- Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCCRecruitingNCT04681469Phase 2
- Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell CarcinomaNot yet recruitingNCT04678791Not applicable
- Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)RecruitingNCT04678102Phase 1
- BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC TreatmentRecruitingNCT04673955
- Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in SituRecruitingNCT04666961Phase 2
- Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCCRecruitingNCT04663035Phase 2
- Urine Omics Predicting IO Therapy Responses in mUC PatientsRecruitingNCT04641936
- Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityRecruitingNCT04631731Phase 1/2
- Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary TractRecruitingNCT04617756Phase 2
- Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCCRecruitingNCT04615143Phase 2
- Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerRecruitingNCT04614103Phase 2
- Umbrella Biomarker-Guided Therapy in NPCNot yet recruitingNCT04605562Phase 2
- A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and NeckRecruitingNCT04597476Phase 2
- Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-RecruitingNCT04595929Not applicable
- Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver TransplantationRecruitingNCT04595864Phase 3
- Magnifying NBI for Occult NPCRecruitingNCT04593186Not applicable
- Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPCRecruitingNCT04557020Phase 3
- Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal CarcinomatosisRecruitingNCT04547725Not applicable
- To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal CarcinomaRecruitingNCT04547673
- Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPCRecruitingNCT04544969
- A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiationNot yet recruitingNCT04534855Phase 2
- Individualized Carbon-Ion Radiotherapy for Patients With Locally Recurrent Nasopharyngeal CarcinomaNot yet recruitingNCT04533620Phase 2
- Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT04522050Phase 1
- Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)RecruitingNCT04519905Not applicable
- The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)Not yet recruitingNCT04517227Not applicable
- Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During RadiotherapyRecruitingNCT04517019Not applicable
- A Multicenter Cancer Biospecimen Collection StudyRecruitingNCT04510129
- Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 TrialRecruitingNCT04502641Phase 3
- A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial CarcinomaRecruitingNCT04486781Phase 2
- TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapYRecruitingNCT04481256Not applicable
- Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal CancerRecruitingNCT04460352Phase 3
- Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal CarcinomaRecruitingNCT04453813Phase 3
- Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal CarcinomaRecruitingNCT04448522Phase 3
- Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal CarcinomaNot yet recruitingNCT04447326Phase 2
- Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal CancerRecruitingNCT04444869Phase 2
- Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )RecruitingNCT04443322Not applicable
- Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal CarcinomaRecruitingNCT04437329Phase 3
- SBRT Versus Ablation for Perivascular Hepatocellular CarcinomaRecruitingNCT04434989Not applicable
- Neo-TACE-HAIC for BCLC B Stage HCCRecruitingNCT04424043Not applicable
- Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular CarcinomaRecruitingNCT04414956Not applicable
- Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT04414566Phase 3
- Toripalimab for Local-regional Recurrent Nasopharyngeal CarcinomaRecruitingNCT04376866Phase 3
- Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal CarcinomatosisRecruitingNCT04370925Phase 3
- To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular CarcinomaRecruitingNCT04365751Not applicable
- Intratumoral Administration of Daromun in Non-melanoma Skin Cancer PatientsRecruitingNCT04362722Phase 2
- Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid CarcinomaRecruitingNCT04354324Not applicable
- SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT04351282Not applicable
- Prospective Cohort of Patients With Hepatocellular Carcinoma in FranceRecruitingNCT04348838
- Cohort of Patients With Hepatocellular Carcinoma or CholangiocarcinomaRecruitingNCT04340986
- Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor ThrombusNot yet recruitingNCT04319484Phase 2/3
- Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical CarcinomaRecruitingNCT04318730Phase 2
- Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.RecruitingNCT04277858Phase 2
- RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph NodesRecruitingNCT04266327Not applicable
- LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS)RecruitingNCT04228237
- Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/BevacizumabRecruitingNCT04224636Phase 2
- IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell CarcinomasRecruitingNCT04224389
- Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT04221516Phase 2
- Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)RecruitingNCT04221464Not applicable
- Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell CarcinomaRecruitingNCT04220749Phase 2
- Integrative Analysis of Pulmonary Sarcomatoid Carcinoma (PSC)Not yet recruitingNCT04215913
- Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRTNot yet recruitingNCT04215510Phase 3
- Adenoid Cystic Carcinoma and Carbon Ion Only IrradiationRecruitingNCT04214366Phase 2
- Nivolumab for Treatment of Squamous Cell Carcinoma of the SkinRecruitingNCT04204837Phase 2
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)RecruitingNCT04198766Phase 1/2
- Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)RecruitingNCT04192253Phase 2
- A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC ClassificationRecruitingNCT04191889Phase 2
- Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNARecruitingNCT04183712Phase 2
- Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel ChemotherapyRecruitingNCT04161664Phase 2
- Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal CarcinomaRecruitingNCT04143984Phase 2
- Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)RecruitingNCT04138212Phase 3
- Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal CarcinomaRecruitingNCT04136886Phase 3
- HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized TrialRecruitingNCT04135690Phase 2
- Longitudinal Study of CRS/HIPEC for Peritoneal CarcinomatosesRecruitingNCT04108936
- p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)RecruitingNCT04104945Not applicable
- Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in SituRecruitingNCT04046159Phase 3
- Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal CarcinomaRecruitingNCT04009265Phase 3
- Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT03964753Phase 2
- Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsRecruitingNCT03924466Phase 2
- Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal CarcinomaRecruitingNCT03919552Phase 3
- Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal CarcinomaRecruitingNCT03908372Phase 2/3
- Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCCRecruitingNCT03899428Phase 2
- Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver CarcinomaRecruitingNCT03895359Phase 3
- Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And NeckRecruitingNCT03830385Phase 2
- Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal CarcinomaRecruitingNCT03790553Phase 3
- Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell CarcinomaRecruitingNCT03787602Phase 1/2
- Comparing Laparoscopic and Open Surgery for Pancreatic CarcinomaRecruitingNCT03785743Not applicable
- Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver FunctionRecruitingNCT03766555Not applicable
- Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)RecruitingNCT03732105Not applicable
- PET/MR in Locally Advanced Nasopharyngeal CarcinomaRecruitingNCT03657017Not applicable
- The Overall Survival of Patients With Unresectable HCC in Real-lifeRecruitingNCT03612726
- A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)RecruitingNCT03592472Phase 3
- Epidermoid Cancer Development in Esophageal AchalasiaRecruitingNCT03546998
- Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal CarcinomaNot yet recruitingNCT03539250Not applicable
- CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and RadiotherapyNot yet recruitingNCT03529279Phase 3